Literature DB >> 25969153

Interaction between Erythrocyte Phospholipid Fatty Acids Composition and Variants of Inflammation-Related Genes on Type 2 Diabetes.

Kelei Li1, Tao Huang, Ju-Sheng Zheng, Jianqin Sun, Yanqiu Chen, Hua Xie, Danfeng Xu, Jianbo Wan, Duo Li.   

Abstract

AIMS: The present study aimed to investigate the interaction between erythrocyte phospholipid (PL) fatty acids and variants of inflammation-related genes in a Chinese population.
METHODS: A total of 622 patients with type 2 diabetes mellitus (T2DM) and 293 healthy subjects were included. Determination of erythrocyte PL fatty acids composition and genotyping of single nucleotide polymorphisms were conducted by standard methods.
RESULTS: A significant interaction of rs7305618 on HNFIA with C18:2n-6 and C20:4n-6 was observed: T allele carriers (TT+CT) had a higher risk of T2DM than noncarriers only when they had a higher level of C18:2n-6 or C20:4n-6, and the odds ratios (ORs) were 2.59 (95% CI 1.58-4.24; p for interaction=0.005) and 2.49 (95% CI 1.47-4.24; p for interaction=0.021), respectively. A significant interaction of rs8078723 at the intergenic region between PSMD3 and CSF3 with C20:5n-3 was observed: C allele carriers (CC+CT) had a lower risk of T2DM than noncarriers only when they had a higher level of C20:5n-3, and the OR was 0.44 (95% CI 0.26-0.73; p for interaction=0.014).
CONCLUSIONS: rs7305618 and rs8078723 were associated with the risk of T2DM in a Chinese population and were modulated by erythrocyte PL fatty acids composition.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25969153     DOI: 10.1159/000381347

Source DB:  PubMed          Journal:  J Nutrigenet Nutrigenomics        ISSN: 1661-6499


  1 in total

1.  Association study of HNF1A in women with polycystic ovary syndrome.

Authors:  Yue Lv; Changfa Sun; Ye Tian; Shigang Zhao; Yuehong Bian; Lei Cheng; Mei Sun; Hong-Bin Liu; Han Zhao; Jinlong Ma
Journal:  J Assist Reprod Genet       Date:  2017-03-15       Impact factor: 3.412

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.